Home>Topics>Companies>Forest Laboratories

Forest Laboratories FRX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. 10 High-Conviction Purchases by Our Ultimate Stock Pickers

      Headlines

      Tue, 21 May 2013

      when expanded out to 25 names) included Air Products & Chemicals APD, American Express AXP, Best Buy BBY, Forest Laboratories FRX, Freeport-McMoRan Copper & Gold FCX, Kohl's KSS, Mondelez International MDLZ, Morgan Stanley MS, Oracle

    2. Almirall, Forest to seek approval for inhaler drug in US, Europe

      Headlines

      Thu, 2 May 2013

      MADRID, May 2 (Reuters) - Spain's Almirall and Forest Laboratories said on Thursday that results of a second phase III clinical trial for a new inhaler were positive and they will seek regulatory approval to sell the drug by the end of the year.

    3. Forest Laboratories Management Discusses Q4 2013 Results - Earnings Call Transcript

      Headlines

      Tue, 23 Apr 2013

      Forest Laboratories ( FRX ) Q4 2013 Earnings Call April 23, 2013 10:00 am ET Executives ..... a href='http://seekingalpha.com/article/1363111- forest - laboratories -management-discusses-q4-2013-results-earnings-call

    4. REFILE-Almirall, Forest report positive results in inhaler trial

      Headlines

      Tue, 16 Apr 2013

      MADRID, April 16 (Reuters) - Spain's Almirall and Forest Laboratories said results of a first phase III clinical trial for Almirall's Genuair inhaler were positive and they would seek regulatory approval to sell the drug if further results proved positive.

    5. Carl Ichan-backed Forest Laboratories (FRX) and Almirall say a combination COPD treatment of aclidinium and formoterol met both endpoints in a Phase III clinical trial. Data from a second Phase III ...

      Headlines

      Tue, 16 Apr 2013

      Carl Ichan-backed Forest Laboratories ( FRX ) and Almirall say a combination COPD treatment of aclidinium and formoterol met both endpoints in a Phase III clinical trial

    6. Synergy Pharmaceuticals ([[SGYP]] +10.3%) soars on heavy volume after Cantor Fitzgerald raises its price target on the shares to $15 from $12. Irina Rivkind says the company's lead investigational ...

      Headlines

      Tue, 9 Apr 2013

      company's lead investigational drug plecanatide can "achieve revenue parity" with Ironwood ( IRWD -0.5% ) and Forest Laboratories ' ( FRX -0.2% ) Linzess, an FDA approved treatment for constipation. Post your comment!

    7. Forest Laboratories Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 10:15 AM

      Headlines

      Wed, 13 Mar 2013

      Forest Laboratories , Inc. ( FRX ) March 13, 2013 10:15 am ET Executives Francis ..... a href='http://seekingalpha.com/article/1270401- forest - laboratories -inc-presents-at-barclays-global-healthcare-conference

    8. Forest Laboratories' Management Presents at Citi 2013 Global Healthcare Conference (Transcript)

      Headlines

      Wed, 27 Feb 2013

      Forest Laboratories , Inc. ( FRX ) February 27, 2013 ..... I am very excited to be hosting Forest Laboratories this morning, and we're very ..... seekingalpha.com/article/1231881- forest - laboratories -inc-presents-at-citi

    9. Forest Laboratories Goes Off Lexapro - What Happens Next?

      Headlines

      Tue, 5 Feb 2013

      By Pharma Reports: Forest Laboratories ( FRX ) launched Lexapro , escitalopram selective serotonin reuptake inhibito r (SSRI) , in September 2002. Lexapro quickly

    10. AstraZeneca Posts Solid Fourth Quarter, but Offers Weak 2013 Guidance and Removes 2014 Guidance

      Commentary

      Thu, 31 Jan 2013

      weak pipeline increases the likelihood that AstraZeneca will look for a major acquisition in 2013, and we think Forest Laboratories FRX is a likely target, as its valuation looks attractive and the firm holds several recently approved drugs

    « Prev12345Next »
    Content Partners